Recruiting studies: Ticagrelor

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Combining Aspirin With Ticagrelor or Cilostazol in Minor Stroke or TIA
Phase 3 · 1 location(s) · Kafrelsheikh University · NCT06591390 Effect of Fan Application in Preventing Ticagrelor-Associated Dyspnea
NA · 2 location(s) · Acibadem University · NCT07268859 Combining Aspirin With Ticagrelor or Clopidogrel in Minor Stroke or TIA
Phase 3 · 1 location(s) · Kafrelsheikh University · NCT06591312 Study of the Long-term Effects of P2Y12 Inhibitor Monotherapy and Coagulation Markers After Percutaneous Coronary Angiop
Phase 3 · 1 location(s) · Cardiocentro Ticino · NCT07582835 Ticagrelor Versus Cilostazol in Ischemic Stroke
Phase 3 · 1 location(s) · Kafrelsheikh University · NCT06561867 Sequential MonotherApy of TicagrElor and Clopidogrel After Coronary Intervention
Phase 4 · 1 location(s) · Second Affiliated Hospital, School of Medicine, Zhejiang Uni · NCT04937699 Ticagrelore Alone Post PCI
Phase 4 · 2 location(s) · Shiraz University of Medical Sciences · NCT06509893 Aspirin-free Strategy With Ticagrelor in Patients With a Myocardial Infarction Treated Medically Alone
Phase 3 · 1 location(s) · Montreal Heart Institute · NCT07257198 Safety of Ticagrelor Monotherapy After Primary Percutaneous Coronary Intervention for ST-elevation Myocardial Infarction
NA · 5 location(s) · Radboud University Medical Center · NCT05986968 Ticagrelor Versus Cilostazol in Minor Ischemic Stroke or TIA
Phase 3 · 1 location(s) · Kafrelsheikh University · NCT06196047 DCS Versus DES for One-month DAPT in Patients With ACS: ONE-PASS Trial
NA · 1 location(s) · Yonsei University · NCT05305482 Ticagrelor With Low-dose Versus Regular Aspirin in Patients With Acute Coronary Syndrome (ACS) at High-Risk for Ischemia
Phase 4 · 1 location(s) · Fu Wai Hospital, Beijing, China · NCT04240834 Evaluation of Low Dose Colchicine and Ticagrelor in Prevention of Ischemic Stroke in Patients With Stroke Due to Atheros
Phase 3 · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT05476991 Ticagrelor Based De-Escalation of Dual Antiplatelet Therapy in Ischemic Stroke
Phase 2/Phase 3 · 1 location(s) · Mazandaran University of Medical Sciences · NCT06653348 Combining Aspirin With Ticagrelor or Cilostazol in Large-vessel Minor Stroke or TIA
Phase 3 · 2 location(s) · Kafrelsheikh University · NCT06591377 Single Antiplatelet Treatment With Ticagrelor or Aspirin After Transcatheter Aortic Valve Implantation
Phase 4 · 1 location(s) · Fundacin Biomedica Galicia Sur · NCT05283356 Effects of Low-dose Ticagrelor vs. Clopidogrel in Stable Patients Undergoing Elective Percutaneous Coronary Intervention
Phase 4 · 1 location(s) · University of Florida · NCT06228456 Future Optimal Research and Care Evaluation
Phase N/A · 4 location(s) · J.M. ten Berg · NCT03823547 Multicentric Study on Clopidogrel Resistance in DAPT for CAS (MULTI-RESCLOSA)
Phase N/A · 1 location(s) · IRCCS Policlinico S. Donato · NCT05566301 Ticagrelor Versus Cilostazol in Large-vessel Ischemic Stroke
Phase 3 · 1 location(s) · Kafrelsheikh University · NCT06202755 One-Month DAPT in CABG Patients
Phase 3 · 22 location(s) · Weill Medical College of Cornell University · NCT05997693 Ticagrelor De-escalation Strategy in AMI Patients
Phase 4 · 1 location(s) · Dong-A University · NCT04755387 Switching From Dual Antiplatelet Therapy to Monotherapy With Potent P2Y12 Inhibitors
Phase 4 · 1 location(s) · University of Florida · NCT06691191 Dual Antithrombotic Therapy With Dabigatran and Ticagrelor in Patients With ACS and Non-valvular AF Undergoing PCI
Phase 4 · 1 location(s) · Medical University of Gdansk · NCT04695106 Combining Aspirin With Ticagrelor or Clopidogrel in Large-vessel Minor Stroke or TIA
Phase 3 · 1 location(s) · Kafrelsheikh University · NCT06591338

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.